JOY ROCHELL THURMAN-NGUYEN M.D.
Prescription History 1477084077
Family Medicine in Seattle, WA

Active since March 24, 2017PECOS EnrolledAccepts Medicare Assignment
125 16TH AVE E, CSB 545, SEATTLE, WA 98112(206) 326-3585 Get Directions

NPPES record last updated: May 18, 2021. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: May 18, 2021, Apr 5, 2021, Dec 4, 2019 and 1 more (4 updates tracked since 2017).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JOY ROCHELL THURMAN-NGUYEN M.D., an active Family Medicine specialist practicing in Seattle, WA. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 30 documented patient claims. Among these therapy options, the most frequently utilized medication is Buprenorphine-Naloxone, which accounts for 18 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

2
Medications
30
Total Claims
30
30-Day Fills
Buprenorphine-Naloxone
Most Prescribed · 18 claims
View details
2 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by JOY ROCHELL THURMAN-NGUYEN M.D. in 2024, with prescription volumes, average cost per fill, and WA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other WA PrescribersVs. WA Avg
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl18$64.29▼ below WA avg▼ Less than typical

About Buprenorphine-Naloxone: This medication contains 2 medicines: buprenorphine and naloxone. Show more ▾

It is used to treat opioid use disorder. Buprenorphine belongs to a class of drugs called mixed opioid agonist-antagonists. Buprenorphine helps prevent withdrawal symptoms caused by stopping other opioids. Naloxone is an opioid antagonist that blocks the effect of opioids and can cause severe opioid withdrawal when injected. Withdrawal is less likely when naloxone is taken by mouth, dissolved under the tongue, or dissolved on the inside of the cheek. It is combined with buprenorphine to prevent abuse and misuse (injection) of this medication. This combination medication is used as part of a complete treatment program for opioid use disorder (such as compliance monitoring, counseling, behavioral contract, lifestyle changes). Ask your doctor or pharmacist if you should have naloxone available to treat opioid overdose. Teach your family or household members about the signs of an opioid overdose and how to treat it. A pharmaceutical preparation that combines buprenorphine, an OPIOID ANALGESICS with naloxone, a NARCOTIC ANTAGONISTS to reduce the potential for NARCOTIC DEPENDENCE in the treatment of pain. It may also be used for OPIOID SUBSTITUTION THERAPY.

In 2024, this provider wrote 18 Medicare prescriptions for Buprenorphine-Naloxone, about a third of the volume of the typical Washington prescriber of this medication (47.4). Medicare paid an average of $64.29 per fill, versus $127.54 statewide.

How often this provider prescribes it

This provider
18
WA average
47.4

This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$64.29
WA average
$127.54

This provider's average cost per fill is below the WA average for this medication.

18
30-Day Fills
standardized to 30-day supplies
133
Days of Medication
total across all patients in 2024
Gabapentin12$10.98▼ below WA avg▼ Less than typical

About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾

It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

In 2024, this provider wrote 12 Medicare prescriptions for Gabapentin, about 17% of the volume of the typical Washington prescriber of this medication (72.3). Medicare paid an average of $10.98 per fill, versus $19.65 statewide.

How often this provider prescribes it

This provider
12
WA average
72.3

This provider prescribes this medication less often than the average WA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$10.98
WA average
$19.65

This provider's average cost per fill is below the WA average for this medication.

12
30-Day Fills
standardized to 30-day supplies
315
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average WA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the WA average cost per fill.

About this data. The prescription history for JOY ROCHELL THURMAN-NGUYEN M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family Medicine prescribing approach at this Seattle, WA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among WA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.